Literature DB >> 18160098

The role of telomere biology in bone marrow failure and other disorders.

Sharon A Savage1, Blanche P Alter.   

Abstract

Telomeres, consisting of nucleotide repeats and a protein complex at chromosome ends, are essential in maintaining chromosomal integrity. Dyskeratosis congenita (DC) is the inherited bone marrow failure syndrome (IBMFS) that epitomizes the effects of abnormal telomere biology. Patients with DC have extremely short telomere lengths (<1st percentile) and many have mutations in telomere biology genes. Interpretation of telomere length in other IBMFSs is less straightforward. Abnormal telomere shortening has been reported in patients with apparently acquired hematologic disorders, including aplastic anemia, myeolodysplasia, paroxysmal nocturnal hemoglobinuria, and leukemia. In these disorders, the shortest-lived cells have the shortest telomeres, suggestive of increased hematopoietic stress. Telomeres are also markers of replicative and/or oxidative stress in other complex disease pathways, such as inflammation, stress, and carcinogenesis. The spectrum of related disorders caused by mutations in telomere biology genes extends beyond classical DC to include marrow failure that does not respond to immunosuppression, idiopathic pulmonary fibrosis, and possibly other syndromes. We suggest that such patients be categorized as having an inherited disorder of telomere biology. Longitudinal studies of patients with very short telomeres but without classical DC are necessary to further understand the long-term sequelae, such as malignancy, osteonecrosis/osteoporosis, and pulmonary and liver disease.

Entities:  

Mesh:

Year:  2007        PMID: 18160098      PMCID: PMC2278290          DOI: 10.1016/j.mad.2007.11.002

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  148 in total

1.  A telomerase component is defective in the human disease dyskeratosis congenita.

Authors:  J R Mitchell; E Wood; K Collins
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation.

Authors:  N Rufer; T H Brümmendorf; B Chapuis; C Helg; P M Lansdorp; E Roosnek
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

Review 3.  Telomerase and cancer.

Authors:  J W Shay; Y Zou; E Hiyama; W E Wright
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

4.  Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation.

Authors:  M Akiyama; O Asai; Y Kuraishi; M Urashima; Y Hoshi; H Sakamaki; H Yabe; T Furukawa; O Yamada; H Mizoguchi; H Yamada
Journal:  Bone Marrow Transplant       Date:  2000-02       Impact factor: 5.483

5.  Telomere shortening in leucocyte subsets of long-term survivors of allogeneic bone marrow transplantation.

Authors:  R Wynn; I Thornley; M Freedman; E F Saunders
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

6.  Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry.

Authors:  T H Brümmendorf; T L Holyoake; N Rufer; M J Barnett; M Schulzer; C J Eaves; A C Eaves; P M Lansdorp
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

7.  Telomere length in leukocyte subpopulations of patients with aplastic anemia.

Authors:  T H Brümmendorf; J P Maciejewski; J Mak; N S Young; P M Lansdorp
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

8.  Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.

Authors:  J M Lipton; N Federman; Y Khabbaze; C L Schwartz; L M Hilliard; J I Clark; A Vlachos
Journal:  J Pediatr Hematol Oncol       Date:  2001-01       Impact factor: 1.289

9.  Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.

Authors:  T J Vulliamy; S W Knight; P J Mason; I Dokal
Journal:  Blood Cells Mol Dis       Date:  2001 Mar-Apr       Impact factor: 3.039

10.  Accelerated telomere shortening and telomerase activation in Fanconi's anaemia.

Authors:  F Leteurtre; X Li; P Guardiola; G Le Roux; J C Sergère; P Richard; E D Carosella; E Gluckman
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

View more
  33 in total

1.  Specificity and stoichiometry of subunit interactions in the human telomerase holoenzyme assembled in vivo.

Authors:  Emily D Egan; Kathleen Collins
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

Review 2.  Hereditary genodermatoses with cancer predisposition.

Authors:  Meg R Gerstenblith; Alisa M Goldstein; Margaret A Tucker
Journal:  Hematol Oncol Clin North Am       Date:  2010-10       Impact factor: 3.722

Review 3.  Telomere biology in hematopoiesis and stem cell transplantation.

Authors:  Shahinaz M Gadalla; Sharon A Savage
Journal:  Blood Rev       Date:  2011-07-20       Impact factor: 8.250

4.  Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia.

Authors:  Konstantia I Pavlaki; Maria-Christina Kastrinaki; Michail Klontzas; Maria Velegraki; Irene Mavroudi; Helen A Papadaki
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

5.  Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita.

Authors:  Ekaterini T Tsilou; Neelam Giri; Sarah Weinstein; Christine Mueller; Sharon A Savage; Blanche P Alter
Journal:  Ophthalmology       Date:  2009-12-22       Impact factor: 12.079

6.  FANCC suppresses short telomere-initiated telomere sister chromatid exchange.

Authors:  David B Rhee; Yisong Wang; Melissa Mizesko; Fang Zhou; Laura Haneline; Yie Liu
Journal:  Hum Mol Genet       Date:  2009-12-18       Impact factor: 6.150

7.  The interaction between the yeast telomerase RNA and the Est1 protein requires three structural elements.

Authors:  Johnathan W Lubin; Timothy M Tucey; Victoria Lundblad
Journal:  RNA       Date:  2012-07-30       Impact factor: 4.942

8.  Danazol Treatment for Telomere Diseases.

Authors:  Danielle M Townsley; Bogdan Dumitriu; Delong Liu; Angélique Biancotto; Barbara Weinstein; Christina Chen; Nathan Hardy; Andrew D Mihalek; Shilpa Lingala; Yun Ju Kim; Jianhua Yao; Elizabeth Jones; Bernadette R Gochuico; Theo Heller; Colin O Wu; Rodrigo T Calado; Phillip Scheinberg; Neal S Young
Journal:  N Engl J Med       Date:  2016-05-19       Impact factor: 91.245

Review 9.  Cancer in dyskeratosis congenita.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

10.  Multiple genetic pathways regulate replicative senescence in telomerase-deficient yeast.

Authors:  Bari J Ballew; Victoria Lundblad
Journal:  Aging Cell       Date:  2013-06-28       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.